Ophthalmology۲۰۲۵کارآزمایی بالینی تصادفی۱۱ استنادنمایه شده در PubMed
Arshad M Khanani, Carl J Danzig, Jeffrey S Heier, Glenn J Jaffe, Peter K Kaiser, David R Lally, Sunil S Patel, Lejla Vajzovic, Christina Y Weng, Hersh Patel, Julie Clark, Dhaval Desai, Don Luo, Erin Henry, Frank G Holz, GATHER2 Trial Investigators
چکیده
Avacincaptad pegol (ACP) is a pegylated RNA aptamer that inhibits complement C5. The efficacy and safety of ACP 2 mg was investigated in GATHER2, with positive year 1 results published. Herein, 2-year results are reported. Phase 3, randomized, sham-controlled study (ClinicalTrials.gov identifier,…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1016/j.ophtha.2025.12.011